LIPHORUS PHARMACEUTICALS
Liphorus Pharmaceuticals is an autocatalytic cleavage of its inhibitory prodomain in the endoplasmic reticulum (ER).
LIPHORUS PHARMACEUTICALS
Industry:
Pharmaceutical
Founded:
2014-01-01
Address:
Montréal, Quebec, Canada
Country:
Canada
Website Url:
http://www.liphorus.com
Status:
Active
Contact:
(514) 564-6474
Email Addresses:
[email protected]
Total Funding:
6.4 M USD
Similar Organizations
Geneos Therapeutics
Geneos Therapeutics is a developer of a neo-antigen based personalized immunotherapy designed to offer cancer treatment.
Idera Pharmaceuticals
Idera Pharmaceuticals is engaged in the discovery and development of novel synthetic DNA and RNA-based drug candidates.
KSQ Therapeutics
KSQ Therapeutics is using CRISPR technology within a powerful drug discovery engine to enable high-confidence drug development.
NephroDI Therapeutics
NephroDI Therapeutics is a biopharmaceutical company that focuses on the concentration disorders of the kidney.
Syros Pharmaceuticals
Syros Pharmaceuticals is a life sciences company that focuses on treating diseases by mapping gene regulatory circuits.
Current Employees Featured
Founder
Investors List
Sanderling Ventures
Sanderling Ventures investment in Series A - Liphorus Pharmaceuticals
Univalor
Univalor investment in Series A - Liphorus Pharmaceuticals
